| 000 | 01596 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515094848.0 | ||
| 264 | 0 | _c20090220 | |
| 008 | 200902s 0 0 eng d | ||
| 022 | _a1463-1326 | ||
| 024 | 7 |
_a10.1111/j.1463-1326.2007.00794.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHovens, M M C | |
| 245 | 0 | 0 |
_aEffects of aspirin on serum C-reactive protein and interleukin-6 levels in patients with type 2 diabetes without cardiovascular disease: a randomized placebo-controlled crossover trial. _h[electronic resource] |
| 260 |
_bDiabetes, obesity & metabolism _cAug 2008 |
||
| 300 |
_a668-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAspirin _xadministration & dosage |
| 650 | 0 | 4 |
_aAtherosclerosis _xdrug therapy |
| 650 | 0 | 4 |
_aC-Reactive Protein _xdrug effects |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 |
_aDiabetic Angiopathies _xprevention & control |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-6 _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSnoep, J D | |
| 700 | 1 | _aGroeneveld, Y | |
| 700 | 1 | _aFrölich, M | |
| 700 | 1 | _aTamsma, J T | |
| 700 | 1 | _aHuisman, M V | |
| 773 | 0 |
_tDiabetes, obesity & metabolism _gvol. 10 _gno. 8 _gp. 668-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1463-1326.2007.00794.x _zAvailable from publisher's website |
| 999 |
_c17550365 _d17550365 |
||